Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.

  • Authors:
    • E Kondo
    • T Furukawa
    • K Yoshinaga
    • H Kijima
    • S Semba
    • T Yatsuoka
    • T Yokoyama
    • S Fukushige
    • A Horii
  • View Affiliations

  • Published online on: September 1, 2000     https://doi.org/10.3892/ijo.17.3.535
  • Pages: 535-576
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Disruption of the DNA mismatch repair (MMR) system has been found to play an important role in sporadic human cancers of several organs such as colorectum, stomach, endometrium, and pancreas. In cancers of the former three organs, disruption of the MMR system is mainly caused by hypermethylation of the hMLH1 gene. We investigated the expression of the hMLH1 and hMSH2 proteins immunohistochemically in pancreatic and endometrial cancers with high frequency microsatellite instability (MSI-H). Loss of expression of hMLH1 was found in none of seven pancreatic cancer, whereas eight (57%) of 14 endometrial cancer showed loss of expression of hMLH1. On the other hand, one (14%) of seven pancreatic cancers and two (14%) of 14 endometrial cancers showed loss of hMSH2 expression. We further analyzed the methylation status at the promoter region of the hMLH1 and hMSH2 genes and found hypermethylation of hMLH1 at the promoter region in the great majority of endometrial cancers with loss of expression. However, no pancreatic cancer showed hypermethylation. We then further analyzed 22 pancreatic cancer cell lines and obtained similar results. These results suggested that MSI-H in pancreatic cancer is probably caused by different mechanisms from those of other sporadic cancers with MSI-H.

Related Articles

Journal Cover

Sep 2000
Volume 17 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kondo E, Furukawa T, Yoshinaga K, Kijima H, Semba S, Yatsuoka T, Yokoyama T, Fukushige S and Horii A: Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.. Int J Oncol 17: 535-576, 2000.
APA
Kondo, E., Furukawa, T., Yoshinaga, K., Kijima, H., Semba, S., Yatsuoka, T. ... Horii, A. (2000). Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.. International Journal of Oncology, 17, 535-576. https://doi.org/10.3892/ijo.17.3.535
MLA
Kondo, E., Furukawa, T., Yoshinaga, K., Kijima, H., Semba, S., Yatsuoka, T., Yokoyama, T., Fukushige, S., Horii, A."Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.". International Journal of Oncology 17.3 (2000): 535-576.
Chicago
Kondo, E., Furukawa, T., Yoshinaga, K., Kijima, H., Semba, S., Yatsuoka, T., Yokoyama, T., Fukushige, S., Horii, A."Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.". International Journal of Oncology 17, no. 3 (2000): 535-576. https://doi.org/10.3892/ijo.17.3.535